University of California San Francisco
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
Scientists at the Gladstone Institutes have discovered how a form of the protein linked to Huntington’s disease influences the timing and severity of its symptoms, offering new avenues for treating not only this disease, but also a variety of similar conditions.
UCSF's leading scientists will participate in five discussions about fascinating topics, such as managing stress to retraining the brain for better performance, as part of the first-ever Bay Area Science Festival.
<p>UCSF biochemist Bruce Alberts has devoted his long career to improving the understanding and appreciation of science, which this week takes center stage at UCSF and beyond as part of the first-ever Bay Area Science Festival.</p>
<p>The San Francisco Bay Area Science Festival offers more than 100 mostly free events to put science and technology at everybody's fingertips and to encourage the next generation of scientists and innovators.</p>
UCSF will celebrate “Clinical Research Education Day’’ as the host of Aware for All – San Francisco, a free health education program that is open to the public and designed to help people make informed decisions about participating in clinical research.
A large, international clinical trial led by doctors at UCSF indicates that a vaccine to prevent anal cancer is safe and effective, according to a study reported in the October 27, 2011 issue of New England Journal of Medicine.
An 11-month-old partnership between UCSF and Pfizer, Inc., aimed at rapidly moving new therapies into human clinical trials, has selected its first projects for funding and joint development.
<p>Three UCSF volunteers are leading a $25-million fundraising campaign to raise funds for brain cancer treatment and research.</p>
<p>The widow of the late Sen. Edward M. Kennedy joined a UCSF panel of caregivers and clinicians who recently explored ways of enhancing the quality of life and care of brain cancer patients.</p>
The California Institute for Quantitative Biosciences (QB3) has signed an agreement with the Johnson & Johnson Corporate Office of Science and Technology (COSAT) to fund University of California proof-of-concept research that brings innovative science to market.
The U.S. Health Resources and Services Administration has funded the UCSF Center for AIDS Prevention Studies to provide leadership and support to seven states implementing interventions to enhance HIV testing and diagnosis.
<p>Former Wall Street executive Gordon Murray, a former patient UCSF, wrote a book after battling brain cancer for more than a year, knowing that he had only a few months to live when he started it.</p>
To prevent the onset of disability in their elderly patients, hospitals should focus on maintaining and restoring patients’ abilities to carry out activities of daily living while they are still inpatients, according to physicians from the San Francisco VA Medical Center and UCSF.